2015 |
Cordyceps militaris |
The Efficacy and Safety of Cordyceps militaris in Korean Adults Who Have Mild Liver Dysfunction |
54 |
Fruiting Body |
1500 mg/day |
2015 |
Cordyceps militaris |
Cordyceps militaris Enhances Cell-Mediated Immunity in Healthy Korean Men |
79 |
Fruiting Body Ethanol Extract |
1500 mg/day |
2016 |
Cordyceps militaris |
Cordyceps militaris Improves Tolerance to High-Intensity Exercise After Acute and Chronic Supplementation |
28 |
Mix including Myceliated Biomass (oats) |
619 mg/day |
2019 |
Cordyceps militaris |
Effects of Cordyceps militaris supplementation on the immune response and upper respiratory infection in healthy adults- a randomized, double-blind, placebo-controlled study |
100 |
Fruiting Body |
300 mg/day |
2021 |
Cordyceps militaris |
Efficacy and Safety of Cordyceps militaris as an Adjuvant to Duloxetine in the Treatment of Insomnia in Patients With Depression: A 6-Week Double-Blind, Randomized, Placebo-Controlled Trial |
59 |
Fruiting Body |
3000 mg/day |
2022 |
Cordyceps militaris |
The effects of Cordyceps militaris fruiting bodies in micturition and prostate size in benign prostatic hyperplasia patients- A pilot study |
62 |
Fruiting Body |
250 mg twice daily |
2023 |
Cordyceps militaris |
Early Trends to Show the Efficacy of Cordyceps militaris in Mild to Moderate COVID Inflammation |
65 |
Fruiting Body |
500 mg three times a day |
2024 |
Cordyceps militaris |
Improved Oxygen Saturation and Performance of Athletes using Cordyceps militaris |
48 |
Fruiting Body |
1000 mg/day |
2020 |
Grifola gargal |
Medicinal Mushroom, Grifola gargal, Lowers Triglyceride in Animal Models of Obesity and Diabetes and in Adults with Prediabetes |
10 |
Fruiting Body extract |
9200 mg/day |
2009 |
Lion’s Mane (Hericium erinaceus) |
Improving Effects of the Mushroom Yamabushitake (Hericium erinaceus) on Mild Cognitive Impairment |
30 |
Fruiting Body |
3000 mg/day |
2010 |
Lion’s Mane (Hericium erinaceus) |
Reduction of Depression and Anxiety by 4 Weeks Hericium erinaceus Intake |
30 |
Fruiting Body |
500 mg/day |
2015 |
Lion’s Mane (Hericium erinaceus) |
The Effects of Hericium erinaceus (Amyloban® 3399) on Sleep Quality and Subjective Well-being |
8 |
Amyloban® 3399 (with Hericenone A) |
– |
2019 |
Lion’s Mane (Hericium erinaceus) |
Improvement of Cognitive Functions by Oral Intake of Hericium erinaceus |
31 |
Fruiting Body |
3200 mg/day |
2019 |
Lion’s Mane (Hericium erinaceus) |
Hericium erinaceus Improves Mood and Sleep Disorders in Patients Affected by Overweight or Obesity |
77 |
Fruiting Body (20%) and Mycelium (80%) |
– |
2020 |
Lion’s Mane (Hericium erinaceus) |
Prevention of Early Alzheimer’s Disease by Erinacine A-Enriched Hericium erinaceus Mycelia |
41 |
Mycelium Enriched With Erinacine A A |
1050 mg/day (with 15 mg/day of Erinacine A A) |
2021 |
Lion’s Mane (Hericium erinaceus) |
Influence of Short-Term Consumption of Hericium erinaceus on Serum Biochemical Markers |
13 |
Mycelium Extract |
3000 mg |
2022 |
Lion’s Mane (Hericium erinaceus) |
Effects of Erinacine A-Enriched Hericium erinaceus on Elderly Hearing-Impaired Patients |
80 |
Mycelium Enriched With Erinacine A A |
2000 mg/day (with 10 mg/day of Erinacine A A) |
2023 |
Lion’s Mane (Hericium erinaceus) |
The Acute and Chronic Effects of Lion’s Mane Mushroom Supplementation on Cognitive Function, Stress and Mood in Young Adults |
41 |
Fruiting Body and Mycelium |
1800 mg/day |
2000 |
Maitake (Grifola frondosa) |
Effects of Maitake (Grifola frondosa) glucan in HIV-infected patients |
35 |
Fruiting Body and/or MD-Fraction |
6000 mg/day or 20 mg +4000 mg/day |
2003 |
Maitake (Grifola frondosa) |
Effect of Maitake (Grifola frondosa) D-Fraction on the Activation of NK Cells in Cancer Patients |
10 |
D-Fraction |
80-300 mg/day |
2004 |
Maitake (Grifola frondosa) |
Safety of Maitake D-Fraction in Healthy Patients |
28 |
D-Fraction |
1 Drop/Kg Body Weight |
2009 |
Maitake (Grifola frondosa) |
A phase I/II trial of a polysaccharide extract from Grifola frondosa (Maitake mushroom) in breast cancer patients: immunological effects |
34 |
Fruiting Body Extract |
2-20 mg/day |
2010 |
Maitake (Grifola frondosa) |
Maitake Mushroom (Grifola frondosa) Extract Induces Ovulation in Patients with Polycystic Ovary Syndrome |
80 |
Extract |
162 mg/day |
2015 |
Maitake (Grifola frondosa) |
Maitake mushroom extract in myelodysplastic syndromes (MDS): a phase II study |
21 |
Fruiting Body Extract |
6 mg/day |
2022 |
Maitake (Grifola frondosa) |
Effect of Maitake D-fraction in advanced laryngeal and pharyngeal cancers during concurrent chemoradiotherapy: A randomized clinical trial |
141 |
D-Fraction |
3000 mg/day |
1999 |
Ophiocordyceps sinensis |
Increased Aerobic Capacity in Healthy Elderly Humans Given a Fermentation Product of Cordyceps CS-4 |
30 |
CS-4 |
3000 mg/day |
2001 |
Ophiocordyceps sinensis |
Supplementation with Cordyceps CS-4 Fermentation Product Promotes Fat Metabolism During Prolonged Exercise |
30 |
CS-4 |
4500 mg/day |
2004 |
Ophiocordyceps sinensis |
Randomized Double-blind Placebo-controlled Clinical Trial and Assessment of Fermentation Product of Cordyceps Sinensis (CS-4) in Enhancing Aerobic Capacity and Respiratory Function of The Healthy Elderly Volunteers |
37 |
CS-4 |
3000 mg/day |
2004 |
Ophiocordyceps sinensis |
CordyMax Enhances Aerobic Capability, Endurance Performance, and Exercise Metabolism in Healthy, Mid-Age to Elderly Sedentary Humans |
131 |
CS-4 |
3000 mg/day |
2004 |
Ophiocordyceps sinensis |
Cordyceps Sinensis (CordyMax CS-4) Supplementation Does Not Improve Endurance Exercise Performance |
22 |
CS-4 |
3000 mg/day |
2005 |
Ophiocordyceps sinensis |
Cordyceps sinensis- and Rhodiola rosea-based Supplementation in Male Cyclists and Its Effect on Muscle Tissue Oxygen Saturation |
8 |
CS-4 |
1,000-2,000 mg/day |
2009 |
Ophiocordyceps sinensis |
Randomized, Double-Blind, Placebo-Controlled Trial of Herbal Therapy for Children with Asthma |
85 |
Mix including Myceliated Biomass (oats) |
0.619 g/day |
2010 |
Ophiocordyceps sinensis |
Effect of CS-4 (Cordyceps sinensis) on Exercise Performance in Healthy Older Subjects: A Double-Blind, Placebo-Controlled Trial |
20 |
CS-4 |
333 mg three times a day |
2016 |
Ophiocordyceps sinensis |
Herbal Medicine Cordyceps sinensis Improves Health-Related Quality of Life in Moderate-to-Severe Asthma |
|
Fruiting Body |
3600 mg/day |
2019 |
Ophiocordyceps sinensis |
Immunomodulatory effects of a β-glucan of Cordyceps (Paecilomyces hepiali; CBG-CS-2): a randomized and double-blind clinical trial |
79 |
β-glucan extract |
1.68 g/day |
2021 |
Ophiocordyceps sinensis |
Applying Cordyceps sinensis to Boost Endurance Performance in Long-Distance Runners |
12 |
– |
Not specified |
2022 |
Ophiocordyceps sinensis |
Effects of cordyceps sinensis supplementation during 12 weeks in amateur marathoners: A randomized, double-blind placebo-controlled trial |
30 |
Fruiting Body |
2000 mg/day |
2024 |
Ophiocordyceps sinensis |
Randomized Double-blind Placebo-controlled Clinical Trial and Assessment of Fermentation Product of Cordyceps Sinensis in Enhancing Aerobic Capacity and Respiratory Function of The Healthy Elderly Volunteers |
37 |
CS-4 |
– |
1995 |
Reishi (Ganoderma lucidum) |
Sensitization to Ganoderma lucidum in Patients with Respiratory Allergy in India |
172 |
Fruitng Body and Spore Extract |
– |
2002 |
Reishi (Ganoderma lucidum) |
A Phase I/II Study of a Ganoderma lucidum (Curt.: Fr.) P. Karst. Extract (Ganopofy) in Patients with Advanced Cancer |
143 |
Ganopoly (β-glucan extract) |
5400 mg/day |
2002 |
Reishi (Ganoderma lucidum) |
A Phase I/II Study of a Ganoderma lucidum (Curt.: Fr.) P. Karst. (Ling Zhi, Reishi Mushroom) Extract in Patients with Chronic Hepatitis B |
90 |
Ganopoly (β-glucan extract) |
– |
2003 |
Reishi (Ganoderma lucidum) |
Effects of Ganopoly1 (A Ganoderma lucidum Polysaccharide Extract) on the Immune Functions in Advanced-Stage Cancer Patients |
34 |
Ganopoly (β-glucan extract) |
5400 mg/day |
2003 |
Reishi (Ganoderma lucidum) |
A Randomized, Placebo-Controlled, Multicenter Study of Ganoderma lucidum (W.Curt.:Fr.) Lloyd (Aphyllophoromycetideae) Polysaccharides (Ganopoly®) in Patients with Advanced Lung Cancer |
68 |
Ganopoly (β-glucan extract) |
1800 mg/day |
2004 |
Reishi (Ganoderma lucidum) |
A Phase I/II Study of Ling Zhi Mushroom Ganoderma lucidum (W.Curt.:Fr.)Lloyd (Aphyllophoromycetideae) Extract in Patients with Type II Diabetes Mellitus |
71 |
Ganopoly (β-glucan extract) |
5400 mg/day |
2004 |
Reishi (Ganoderma lucidum) |
A Phase I/II Study of Ling Zhi Mushroom Ganoderma lucidum (W.Curt.:Fr.) Lloyd (Aphyllophoromycetideae) Extract in Patients with Coronary Heart Disease |
168 |
Ganopoly (β-glucan extract) |
– |
2005 |
Reishi (Ganoderma lucidum) |
Phase I Study of a Methanol Extract of Ganoderma lucidum, Edible and Medicinal Mushroom, in Men with Mild Symptoms of Bladder Outlet Obstruction |
50 |
Methanol Extract |
0.6, 6, or 60 mg/day |
2005 |
Reishi (Ganoderma lucidum) |
Immune Responses to Water-Soluble Ling Zhi Mushroom Ganoderma lucidum (W.Curt.:Fr.) P. Karst. Polysaccharides in Patients with Advanced Colorectal Cancer |
47 |
Ganopoly (β-glucan extract) |
5400 mg/day |
2005 |
Reishi (Ganoderma lucidum) |
Effects of Water-Soluble Ganoderma lucidum Polysaccharides on the Immune Functions of Patients with Advanced Lung Cancer |
36 |
Ganopoly (β-glucan extract) |
5400 mg/day |
2005 |
Reishi (Ganoderma lucidum) |
A Randomized, Double-Blind and Placebo-Controlled Study of a Ganoderma lucidum Polysaccharide Extract in Neurasthenia |
132 |
Ganopoly (β-glucan extract) |
5400 mg/day |
2005 |
Reishi (Ganoderma lucidum) |
A Prospective, Randomized, Double-Blind, Placebo-Controlled Study of the Platelet and Global Hemostatic Effects of Ganoderma Lucidum (Ling-Zhi) in Healthy Volunteers |
40 |
Ganopoly (β-glucan extract) |
1500 mg/day |
2007 |
Reishi (Ganoderma lucidum) |
Safety and Tolerability of Ganoderma lucidum in Healthy Subjects: A Double-Blind Randomized Placebo-Controlled Trial |
16 |
Fruiting Body and Spore Extract |
4000 mg/day (1.89% terpenoids and 15.8% polysaccharides) |
2007 |
Reishi (Ganoderma lucidum) |
Safety and Efficacy of Ganoderma lucidum (Lingzhi) and San Miao San Supplementation in Patients With Rheumatoid Arthritis: A Double-Blind, Randomized, Placebo-Controlled Pilot Trial |
65 |
Unspecified Extract |
4000 mg/day |
2007 |
Reishi (Ganoderma lucidum) |
Potential Benefits of Ling Zhi or Reishi Mushroom Ganoderma lucidum (W. Curt.: Fr.) P. Karst. (Aphyllophoromycetideae) to Breast Cancer Patients |
1 |
Triterpene-enriched polysaccharide extract |
– |
2007 |
Reishi (Ganoderma lucidum) |
Effect of an Extract of Ganoderma lucidum in Men with Lower Urinary Tract Symptoms: A Double-Blind, Placebo-Controlled Randomized and Dose-Ranging Study |
88 |
Unspecified Extract |
0.6, 6, or 60 mg/day |
2008 |
Reishi (Ganoderma lucidum) |
Randomized Clinical Trial of an Ethanol Extract of Ganoderma Lucidum in Men with Lower Urinary Tract Symptoms |
88 |
Fruiting Body Alcohol Extract |
6 mg/day |
2011 |
Reishi (Ganoderma lucidum) |
Study of Potential Cardioprotective Effects of Ganoderma Lucidum (Lingzhi): Results of a Controlled Human Intervention Trial |
26 |
Unspecified Extract |
1440 mg/day |
2011 |
Reishi (Ganoderma lucidum) |
Spore Powder of Ganoderma Lucidum Improves Cancer-Related Fatigue in Breast Cancer Patients Undergoing Endocrine Therapy: A Pilot Clinical Trial |
48 |
Spore Powder |
3000 mg/day |
2013 |
Reishi (Ganoderma lucidum) |
Preliminary Study of the Applications of Ganoderma Lucidum in Chronic Fatigue Syndrome |
50 |
Unspecified Extract |
2000 mg/day |
2014 |
Reishi (Ganoderma lucidum) |
Control of Oral Human Papillomavirus (HPV) by Medicinal Mushrooms, Trametes versicolor and Ganoderma lucidum: A Preliminary Clinical Trial |
61 |
Fruiting Body |
200 mg/day |
2015 |
Reishi (Ganoderma lucidum) |
Useful Treatment of Severe Atopic Dermatitis with Ganoderma Lucidum: A Multiple-Case Study |
4 |
Fruiting Body |
2700 mg/day |
2015 |
Reishi (Ganoderma lucidum) |
A Randomized Double Blinded Study of Ganoderma lucidum (Lingzhi) in Salvage Setting of Recurrent Gynecologic Cancer |
60 |
Fruiting Body + Spores Water Extract |
6000 mg/day |
2016 |
Reishi (Ganoderma lucidum) |
A Double-Blind, Randomized, Placebo-Controlled Trial of Ganoderma lucidum for the Treatment of Cardiovascular Risk Factors of Metabolic Syndrome |
84 |
10:1 Fruiting Body Extract (75%) + Spores (25%) |
3000 mg/day |
2017 |
Reishi (Ganoderma lucidum) |
Triterpenoids and Polysaccharide Peptides-Enriched Ganoderma Lucidum: A Randomized, Double-Blind Placebo-Controlled Crossover Study of Its Antioxidation and Hepatoprotective Efficacy in Healthy Volunteers |
42 |
Extract (7% ganoderic acids and 6% β-Glucan) |
225 mg/day |
2017 |
Reishi (Ganoderma lucidum) |
The Role of Ganoderma Lucidum Uptake on Some Hematological and Immunological Response in Patients with Coronavirus (COVID-19) |
150 |
Unspecified Extract |
– |
2017 |
Reishi (Ganoderma lucidum) |
Cost-Utility Analysis of a Six-Weeks Ganoderma Lucidum-Based Treatment for Women with Fibromyalgia: A Randomized Double-Blind, Active Placebo-Controlled Trial |
26 |
Micromilled Ganoderma lucidum |
6000 mg/day |
2018 |
Reishi (Ganoderma lucidum) |
Spore Powder of Ganoderma Lucidum for the Treatment of Alzheimer Disease: A Pilot Study |
42 |
Spore Powder |
– |
2018 |
Reishi (Ganoderma lucidum) |
Randomized Clinical Trial for the Evaluation of Immune Modulation by Yogurt Enriched with β-Glucans from Lingzhi or Reishi Medicinal Mushroom, Ganoderma lucidum (Agaricomycetes), in Children from Medellín, Colombia |
124 |
β-glucans extract |
– |
2018 |
Reishi (Ganoderma lucidum) |
Immunostimulatory and Anti-inflammatory Effect of Ganoderma Lucidum on Breast Cancer Patients |
40 |
Ganoderma Lucidum capsules |
2000 mg/day |
2019 |
Reishi (Ganoderma lucidum) |
β-1,3/1,6-d-glucan Of Indonesian Ganoderma Lucidum β-glucan Reduces Systolic Blood Pressure & Inflammation In Hypertensive Patients |
50 |
β-glucan extract |
540 mg/day |
2020 |
Reishi (Ganoderma lucidum) |
Transarterial Chemoembolization in Hepatocellular Carcinoma: A Clinical Efficacy Study of Ganoderma Lucidum Extract Polysaccharide Peptide β-Glucan |
63 |
β-glucan extract |
– |
2020 |
Reishi (Ganoderma lucidum) |
Ganoderma lucidum Polysaccharide Peptide Reduce Inflammation and Oxidative Stress in Patient with Atrial Fibrillation |
38 |
PPGL (β-glucan extract) |
750 mg/day |
2020 |
Reishi (Ganoderma lucidum) |
Ganoderma Lucidum Effects on Mood and Health-Related Quality of Life in Women with Fibromyalgia |
64 |
Fruiting Body |
6000 mg/day |
2020 |
Reishi (Ganoderma lucidum) |
Effects of a Combination of Elderberry and Reishi Extracts on the Duration and Severity of Respiratory Tract Infections in Elderly Subjects: A Randomized Controlled Trial |
60 |
Fruiting Body (standardized to 35% polysaccharides) |
500 mg/day |
2020 |
Reishi (Ganoderma lucidum) |
Dynamic biomarkers indicate the immunological benefits provided by Ganoderma spore powder in post-operative breast and lung cancer patients |
120 |
Spore Powder |
4000 mg/day |
2021 |
Reishi (Ganoderma lucidum) |
A Placebo-Controlled, Pseudo-Randomized, Crossover Trial of Botanical Agents for Gulf War Illness: Reishi Mushroom (Ganoderma lucidum), Stinging Nettle (Urtica dioica), and Epimedium (Epimedium sagittatum) |
29 |
Fruiting Body + Extract |
– |
2022 |
Reishi (Ganoderma lucidum) |
Evaluation of Immune Modulation by β-1,3; 1,6 D-Glucan Derived from Ganoderma lucidum in Healthy Adult Volunteers, A Randomized Controlled Trial |
135 |
β-glucan extract |
200 mg/day |
2022 |
Reishi (Ganoderma lucidum) |
The Efficacy of Ganoderma lucidum in Overweight Individuals: A Randomized Placebo-controlled trial |
72 |
Fruiting Body + Extract |
780 mg/day |
2022 |
Reishi (Ganoderma lucidum) |
The Potential Activity of Lingzhi or Reishi Medicinal Mushroom, Ganoderma lucidum (Agaricomycetes), to Alleviate Liver Injury in Adults with Acute Mushroom Poisoning: A Retrospective Study |
61 |
– |
– |
2023 |
Reishi (Ganoderma lucidum) |
Combination Treatment in Ulcerative Colitis Using 5-Aminosalysilic Acid (5-ASA) and Polysaccharide Peptide of Indonesian Ganoderma lucidum β-glucan |
124 |
PPGL (β-glucan extract) |
540 mg/day |
2023 |
Reishi (Ganoderma lucidum) |
Medicinal Mushroom, Ganoderma Lucidum, Improves Painful Symptoms in Patients with Restless Legs Syndrome |
20 |
Unspecified Extract |
920 mg/day |
2024 |
Reishi (Ganoderma lucidum) |
Survival Benefits of Ganoderma Lucidum in Early-stage Triple-negative Breast Cancer: A Real World Study |
142 |
Spore Powder |
– |
1992 |
Shiitake (Lentinula edodes) |
Immunological Analysis and Clinical Effects of Intraabdominal and Intrapleural Injection of Lentinan for Malignant Ascites and Pleural Effusion |
16 |
Lentinan |
4 mg/week intracavitary injection |
1992 |
Shiitake (Lentinula edodes) |
Enhanced Production of Interleukin 1 and Tumor Necrosis Factor by Peripheral Monocytes After Lentinan Administration in Patients with Gastric Carcinoma |
10 |
Lentinan |
2 mg intravenously |
1992 |
Shiitake (Lentinula edodes) |
Enhanced Induction of Lymphokine-Activated Killer Activity After Lentinan Administration in Patients with Gastric Carcinoma |
15 |
Lentinan |
2 mg intravenously |
1998 |
Shiitake (Lentinula edodes) |
Eosinophilia and Gastrointestinal Symptoms After Ingestion of Shiitake Mushrooms |
10 |
Fruiting Body |
4000 mg/day |
1998 |
Shiitake (Lentinula edodes) |
A Placebo-Controlled Trial of the Immune Modulator, Lentinan, in HIV-Positive Patients: A Phase I/II Trial |
98 |
Lentinan |
10, 5, 2, or 1 mg/day |
1999 |
Shiitake (Lentinula edodes) |
The preoperative administration of lentinan ameliorated the impairment of natural killer activity after cardiopulmonary bypass |
25 |
Lentinan |
2mg/day intravenously |
2002 |
Shiitake (Lentinula edodes) |
Effects of a Mushroom β-glucan on the Treatment of Prostate Cancer |
62 |
β-glucan extract |
≈1000mg/10kg BW |
2006 |
Shiitake (Lentinula edodes) |
Efficacy of Lentinan Combined with Chemotherapy in Advanced Non-Small Cell Lung Cancer |
81 |
Lentinan |
– |
2008 |
Shiitake (Lentinula edodes) |
Clinical Application of a Combination Therapy of Lentinan, Multi-Electrode RFA and TACE in HCC |
78 |
Lentinan |
500 mg/day |
2010 |
Shiitake (Lentinula edodes) |
Dietary Administration of Mushroom β-glucans in Patients with Early Stage Prostate Cancers Managed Expectantly: A Phase II Study |
74 |
AHCC (β-glucan extract) |
4500 mg/day |
2010 |
Shiitake (Lentinula edodes) |
Efficacy of Orally Administered Superfine Dispersed Lentinan (β-1,3-Glucan) for the Treatment of Advanced Colorectal Cancer |
80 |
SDL (Superfine dispersed lentinan) |
15 mg/day |
2011 |
Shiitake (Lentinula edodes) |
Supplementation with a Soluble Beta-Glucan Exported from Shiitake Medicinal Mushroom, Lentinus edodes (Berk.) Singer Mycelium: a Crossover, Placebo-Controlled Study in Healthy Elderly |
42 |
Lentinan |
2.5 mg/day |
2011 |
Shiitake (Lentinula edodes) |
Lentinan prolonged survival in patients with gastric cancer receiving S-1-based chemotherapy |
68 |
Lentinan |
– |
2011 |
Shiitake (Lentinula edodes) |
Efficacy of Orally Administered Lentinula edodes Mycelia Extract for Advanced Gastrointestinal Cancer Patients Undergoing Cancer Chemotherapy- a Pilot Study |
8 |
β-glucan extract |
– |
2011 |
Shiitake (Lentinula edodes) |
Efficacy and Safety of Orally Administered Lentinula edodes Mycelia Extract for Patients Undergoing Cancer Chemotherapy: A Pilot Study |
7 |
β-glucan extract |
1800 mg/day |
2011 |
Shiitake (Lentinula edodes) |
Combination therapy with lentinan improves outcomes in patients with esophageal carcinoma |
50 |
Lentinan |
1 mg |
2011 |
Shiitake (Lentinula edodes) |
Clinical observation of thermotherapy combined with thoracic injection of lentinan in treatment of cancerous hydrothorax of patients with lung cancer |
60 |
Lentinan (β-glucan extract) |
– |
2011 |
Shiitake (Lentinula edodes) |
Testing a Low Molecular Mass Fraction of a Mushroom (Lentinus edodes) Extract Formulated as an Oral Rinse in a Cohort of Volunteers |
90 |
Fruiting Body Extract |
– |
2012 |
Shiitake (Lentinula edodes) |
The Anticaries Effect of a Food Extract (Shiitake) in a Short-Term Clinical Study |
30 |
Fruiting Body Extract |
– |
2012 |
Shiitake (Lentinula edodes) |
The Effect of Lentinan Combination Therapy for Unresectable Advanced Gastric Cancer |
39 |
Lentinan |
2 mg |
2013 |
Shiitake (Lentinula edodes) |
Efficacy of Oral Administration of Lentinula edodes Mycelia Extract for Breast Cancer Patients Undergoing Postoperative Hormone Therapy |
20 |
β-glucan extract |
1800 mg |
2014 |
Shiitake (Lentinula edodes) |
Dietary Supplementation with Rice Bran Fermented with Lentinus edodes Increases Interferon-\u03b3 Activity without Causing Adverse Effects: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study |
80 |
Mycelliated Substrate |
3000 mg/day |
2015 |
Shiitake (Lentinula edodes) |
Consuming Lentinula edodes (Shiitake) Mushrooms Daily Improves Human Immunity: A Randomized Dietary Intervention in Healthy Young Adults |
52 |
Fruiting Body |
5 or 10 g/day |
2016 |
Shiitake (Lentinula edodes) |
Randomized phase III study of S-1 alone versus S-1 plus lentinan for unresectable or recurrent gastric cancer |
309 |
Lentinan |
2 mg/body |
2016 |
Shiitake (Lentinula edodes) |
Polysaccharide from Lentinus edodes for Integrative Cancer Treatment: Immunomodulatory Effects on Lymphocyte Population |
7 |
AHCC (β-glucan extract) |
300 mg/day |
2016 |
Shiitake (Lentinula edodes) |
Improvement of QOL and Immunological Function With Lentinula Edodes Mycelia in Patients Undergoing Cancer Immunotherapy: An Open Pilot Study |
10 |
Randomized phase III study of S-1 alone versus S-1 plus lentinan for unresectable or recurrent gastric cancer |
1800 mg/d |
2016 |
Shiitake (Lentinula edodes) |
Chemo-Immunotherapy Using Lentinan for the Treatment of Gastric Cancer with Liver Metastases |
12 |
Lentinan |
2 mg |
2016 |
Shiitake (Lentinula edodes) |
A phase II study of a combination treatment of alternate-day S-1 and lentinan as first-line chemotherapy for unresectable or recurrent gastric cancer |
37 |
Lentinan |
2 mg/body |
2017 |
Shiitake (Lentinula edodes) |
Lentinula edodes mycelia extract plus adjuvant chemotherapy for breast cancer patients: Results of a randomized study on host quality of life and immune function improvement |
47 |
β-glucan extract |
1,800 mg/day |
2018 |
Shiitake (Lentinula edodes) |
Immunomodulatory Effect of Lentinan on Aberrant T Subsets and Cytokines Profile in Non-small Cell Lung Cancer Patients |
73 |
Lentinan |
4 mg/day |
2018 |
Shiitake (Lentinula edodes) |
Clinical effects of lentinan combined with budesonide inhalation in treating acute exacerbation of chronic obstructive pulmonary disease under mechanical ventilation |
72 |
Lentinan |
0.5 g |
2018 |
Shiitake (Lentinula edodes) |
Lentinan combined with cisplatin and paclitaxel in the treatment of patients with ovarian cancer with ascites |
212 |
Lentinan |
– |
2019 |
Shiitake (Lentinula edodes) |
An open label trial of a standardized extract of cultured Lentinula edodes mycelia (ECLM) in children with refractory epilepsy |
18 |
β-glucan extract |
0.6 g/day |
2020 |
Shiitake (Lentinula edodes) |
S-1 Plus Leucovorin and Oxaliplatin in Combination with Lentinan as First-line Therapy in Patients with Metastatic Gastric Cancer |
12 |
Lentinan |
– |
2020 |
Shiitake (Lentinula edodes) |
A Quality-of-Life Study in Healthy Adults Supplemented with Lentinex\u00ae Beta-Glucan of Shiitake Culinary\u2212Medicinal Mushroom, Lentinus edodes (Agaricomycetes) |
63 |
Lentinan |
1-2 mg |
2020 |
Shiitake (Lentinula edodes) |
Modulation of T Regulatory and Dendritic Cell Phenotypes Following Ingestion of Bifidobacterium longum, AHCC\u00ae and Azithromycin in Healthy Individuals |
40 |
AHCC (β-glucan extract) |
– |
2021 |
Shiitake (Lentinula edodes) |
Preventing Recurrence of Hepatocellular Carcinoma After Curative Hepatectomy With Active Hexose-correlated Compound Derived From Lentinula edodes Mycelia |
29 |
AHCC (β-glucan extract) |
1000 mg |
2021 |
Shiitake (Lentinula edodes) |
Modulation of human intestinal microbiota in a clinical trial by consumption of a \u03b2\u2010d\u2010glucan\u2010enriched extract obtained from Lentinula edodes |
52 |
Fruiting Body Extract |
3.5 g/day |
2021 |
Shiitake (Lentinula edodes) |
Lentinan Combined with (125)I Brachytherapy for Recurrent Ovarian Cancer |
160 |
Lentinan |
– |
2021 |
Shiitake (Lentinula edodes) |
Effects of Shiitake Culinary-Medicinal Mushroom, Lentinus edodes (Agaricomycetes), Bars on Lipid and Antioxidant Profiles in Individuals with Borderline High Cholesterol: A Double-Blind Randomized Clinical Trial |
68 |
Fruiting Body |
– |
2023 |
Shiitake (Lentinula edodes) |
Safety and efficacy of lentinan nasal drops in patients infected with the variant of COVID-19: a randomized, placebo-controlled trial |
70 |
Lentinan |
100 mg/day |
2023 |
Shiitake (Lentinula edodes) |
Efficacy of Lentinula edodes Mycelia Extract on Chemotherapy-Related Tasted Disorders in Pancreatic Cancer Patients |
98 |
AHCC (β-glucan extract) |
– |
2017 |
Turkey Tail (Trametes versicolor) |
Coriolus versicolor (Yunzhi) Use as Therapy in Advanced Hepatocellular Carcinoma Patients with Poor Liver Function or Who Are Unfit for Standard Therapy |
15 |
PSP(β-glucan extract) |
2.4 g g/day |
2022 |
Turkey Tail (Trametes versicolor) |
Efficacy of a Coriolus versicolor-Based Vaginal Gel in Human Papillomavirus-Positive Women Older Than 40 Years: A Sub-Analysis of PALOMA Study |
41 |
Topical Gel (Papilocare®) |
Papilocare® vaginal gel once daily for 21 days, followed by 7 days rest, for 1 or 3 months. Then, alternate-day therapy for 5 or 3 months. |
1986 |
Turkey Tail (Trametes versicolor) |
Clinical results of a randomized controlled trial on the effect of adjuvant immunochemotherapy using Esquinon and Krestin in patients with curatively resected gastric cancer |
279 |
PSK (β-glucan extract) |
2000 mg/m2/day |
1988 |
Turkey Tail (Trametes versicolor) |
Clinical effect of postoperative adjuvant immunochemotherapy with the FT-207 suppository and PSK in colorectal cancer patients |
124 |
PSK (β-glucan extract) |
3000 mg/day |
1988 |
Turkey Tail (Trametes versicolor) |
Postoperative Adjuvant Immunochemotherapy with Mitomycin Futraful and PSK for Gastric Cancer |
579 |
PSK (β-glucan extract) |
3000 mg/day |
1989 |
Turkey Tail (Trametes versicolor) |
Adjuvant PSK Immunotherapy in Patients with Carcinoma of the Nasopharynx |
38 |
PSK (β-glucan extract) |
1000 mg/day |
1989 |
Turkey Tail (Trametes versicolor) |
An effect of adjuvant immunochemotherapy using krestin and 5-FU on gastric cancer patients with radical surgery (first report)–a randomized controlled trial by the cooperative study group |
262 |
PSK (β-glucan extract) |
3000 mg/day |
1990 |
Turkey Tail (Trametes versicolor) |
Significant prolongation of disease-free period gained by oral polysaccharide K (PSK) administration after curative surgical operation of colorectal cancer |
111 |
PSK (β-glucan extract) |
3000 mg/day followed 2/g day |
1992 |
Turkey Tail (Trametes versicolor) |
Randomized Adjuvant Trial to Evaluate the Addition of Tamoxifen and PSK to Chemotherapy in Patients with Primary Breast Cancer |
967 |
PSK (β-glucan extract) |
– |
1992 |
Turkey Tail (Trametes versicolor) |
Randomized, Controlled Study on Adjuvant Immunochemotherapy with PSK in Curatively Resected Colorectal Cancer |
448 |
PSK (β-glucan extract) |
– |
1993 |
Turkey Tail (Trametes versicolor) |
Effect of krestin PSK as Adjuvant Treatment on the Prognosis after Radical Radiotherapy in Patients with Non-Small Cell Lung Cancer |
185 |
PSK (β-glucan extract) |
– |
1994 |
Turkey Tail (Trametes versicolor) |
Efficacy of Immunochemotherapy as Adjuvant Treatment after Curative Resection of Gastric Cancer |
262 |
PSK (β-glucan extract) |
– |
1994 |
Turkey Tail (Trametes versicolor) |
Oxidative Stress Relief for Cancer-Bearing Hosts by the Protein-Bound Polysaccharide of Coriolus versicolor QUEL with SOD Mimicking Activity |
18 |
PSK (β-glucan extract) |
3000 mg/day |
1995 |
Turkey Tail (Trametes versicolor) |
Immunochemotherapies versus Chemotherapy as Adjuvant Treatment after Curative Resection of Operable Breast Cancer |
227 |
PSK (β-glucan extract) |
– |
1995 |
Turkey Tail (Trametes versicolor) |
Immunotherapy for Esophageal Cancer: A Randomized Trial in Combination with Radiotherapy and Radiochemotherapy |
174 |
PSK (β-glucan extract) |
– |
1996 |
Turkey Tail (Trametes versicolor) |
Postoperative Adjuvant Randomised Trial Comparing Chemoendocrine Therapy, Chemotherapy and Immunotherapy for Patients with Stage II Breast Cancer: 5-year Results |
916 |
PSK (β-glucan extract) |
3000 mg/day |
1997 |
Turkey Tail (Trametes versicolor) |
HLA Antigen as Predictive Index for the Outcome of Breast Cancer Patients with Adjuvant Immunochemotherapy with PSK |
134 |
PSK (β-glucan extract) |
3000 mg/day |
2003 |
Turkey Tail (Trametes versicolor) |
Adjuvant Therapy With Protein-Bound Polysaccharide K and Tegafur Uracil in Patients With Stage II or III Colorectal Cancer: Randomized, Controlled Trial |
201 |
PSK (β-glucan extract) |
3000 mg/day |
2003 |
Turkey Tail (Trametes versicolor) |
Coriolus versicolor Polysaccharide Peptide Slows Progression of Advanced Non-Small Cell Lung Cancer |
68 |
PSP(β-glucan extract) |
3060 mg/day |
2004 |
Turkey Tail (Trametes versicolor) |
Adjuvant Immunochemotherapy with Oral Tegafur/Uracil Plus PSK in Patients with Stage II or III Colorectal Cancer: A Randomized Controlled Study |
205 |
PSK (β-glucan extract) |
3000 mg/day |
2004 |
Turkey Tail (Trametes versicolor) |
Effect of Adjuvant Immunochemotherapy with PSK for Colon Cancer Patients Showing Oncogenic \u03b2-Catenin Activation in Primary Tumor |
202 |
PSK (β-glucan extract) |
3000 mg/day |
2004 |
Turkey Tail (Trametes versicolor) |
Long-term Effect of 5-Fluorouracil Enhanced by Intermittent Administration of Polysaccharide K after Curative Resection of Colon Cancer: A Randomized Controlled Trial for 7-Year Follow-up |
446 |
PSK (β-glucan extract) |
3000 mg/day |
2004 |
Turkey Tail (Trametes versicolor) |
Immunomodulatory Effects of Yun Zhi and Danshen Capsules in Healthy Subjects—a Randomized, Double-Blind, Placebo-Controlled, Crossover Study |
100 |
PSP(β-glucan extract) |
50 mg/kg body weight |
2005 |
Turkey Tail (Trametes versicolor) |
Immunomodulatory Activities of Yunzhi and Danshen in Post-treatment Breast Cancer Patients |
82 |
PSP(β-glucan extract) |
50 mg/kg body weight |
2006 |
Turkey Tail (Trametes versicolor) |
Beneficial Effects of Protein-Bound Polysaccharide K Plus Tegafur/Uracil in Patients with Stage II or III Colorectal Cancer: Analysis of Immunological Parameters |
205 |
PSK (β-glucan extract) |
3000 mg/day |
2006 |
Turkey Tail (Trametes versicolor) |
Clinical Studies of Immunomodulatory Activities of Yunzhi-Danshen in Patients with Nasopharyngeal Carcinoma |
27 |
PSK (β-glucan extract) |
3600 mg/day |
2007 |
Turkey Tail (Trametes versicolor) |
Adjuvant Immunochemotherapy with Protein-Bound Polysaccharide K for Colon Cancer in Relation to Oncogenic β-Catenin Activation |
202 |
PSK (β-glucan extract) |
– |
2007 |
Turkey Tail (Trametes versicolor) |
In vivo effect of I’m-Yunity on hepatic cytochrome P450 3A4 |
12 |
PSP(β-glucan extract) |
– |
2012 |
Turkey Tail (Trametes versicolor) |
Phase 1 Clinical Trial of Trametes versicolor in Women with Breast Cancer |
11 |
Myceliated Substrate (not specified; from fungi perfecti) |
3, 6, or 9 g/day |
2014 |
Turkey Tail (Trametes versicolor) |
Effects of polysaccharopeptide from Trametes Versicolor and amoxicillin on the gut microbiome of healthy volunteers |
24 |
PSP(β-glucan extract) |
– |
2017 |
Turkey Tail (Trametes versicolor) |
Phase III Trial Comparing UFT + to UFT + LV in Stage IIB, III Colorectal Cancer |
357 |
PSK (β-glucan extract) |
3000 mg/day |
2017 |
Turkey Tail (Trametes versicolor) |
Randomized Phase III Trial Comparing Surgery Alone to UFT+ PS for Stage II Rectal Cancer (JFMC38 Trial) |
111 |
PSK (β-glucan extract) |
3000 mg/day |
2024 |
Turkey Tail (Trametes versicolor) |
Adjuvant Chemotherapy With UFT/LV Versus UFT/LV Plus PSK in Stage II/III Colorectal Cancer |
186 |
PSK (β-glucan extract) |
3000 mg/day |
2011 |
(specific compound) |
The Bioavailability of Ergothioneine from Mushrooms and Effects on Antioxidant Capacity and Inflammation |
10 |
Ergothioneine |
8g or 16g mushroom powder |
2012 |
(specific compound) |
Improvement of Joint ROM and Reduction of Chronic Pain with Ergothioneine-Containing Supplement |
12 |
Ergothioneine |
Unspecified |
2014 |
(specific compound) |
Clinical and Biochemical Correlates of Serum L-Ergothioneine |
439 |
Ergothioneine |
Observational study (no supplementation) |
2017 |
(specific compound) |
Administration of Pure Ergothioneine to Healthy Subjects |
47 |
Ergothioneine |
5 mg and 25 mg daily |
2022 |
(specific compound) |
Low Plasma Ergothioneine Predicts Cognitive and Functional Decline in the Elderly |
470 |
Ergothioneine |
Observational study (no supplementation) |
2024 |
(specific compound) |
Investigating Ergothioneine to Delay Cognitive Decline in Mild Cognitively Impaired Subjects |
19 |
Ergothioneine |
25 mg 3 times per week |
2023 |
Tremella fuciformis |
Effectiveness of Fish Roe, Snow Fungus, and Yeast Supplementation for Cognitive Function: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial |
64 |
Fruiting Body Extract |
56 mg/day for 8 weeks |
2012 |
Tremella mesenterica |
Yellow brain culinary-medicinal mushroom, Tremella mesenterica Ritz.:Fr. (higher Basidiomycetes), is subjectively but not objectively effective for eradication of Helicobacter pylori: a prospective controlled trial |
52 |
Fruiting Body Extract |
4 g/day for 10 days |
2018 |
Tremella fuciformis |
Efficacy and Safety of Tremella fuciformis in Individuals with Subjective Cognitive Impairment: A Randomized Controlled TrialEdit | Quick Edit | Trash | View |
75 |
Fruiting Body Extract |
600 or 1200 mg/day |
2019 |
Agaricus blazei (Royal Sun Agaric) |
Agaricus blazei-Based Mushroom Extract Supplementation to Birch Allergic Blood Donors |
60 |
AndoSan™ (Agaricus blazei-based) |
60 ml/day |
2011 |
Agaricus blazei (Royal Sun Agaric) |
Agaricus blazei Murrill and Inflammatory Mediators in Elderly Women |
57 |
Fruiting Body Extract |
900 mg/day |
2008 |
Agaricus blazei (Royal Sun Agaric) |
The Mushroom Agaricus blazei Murill Extract Normalizes Liver Function in Patients with Chronic Hepatitis B |
4 |
Fruiting Body Extract |
1500 mg/day |
2007 |
Agaricus blazei (Royal Sun Agaric) |
The Mushroom Agaricus blazei Murill in Combination with Metformin and Gliclazide Improves Insulin Resistance in Type 2 Diabetes |
60 |
Fruiting Body Extract |
1500 mg/day |
2015 |
Agaricus blazei (Royal Sun Agaric) |
Immunomodulatory Effects of the Agaricus blazei Murill-Based Mushroom Extract AndoSan™ in Patients with Multiple Myeloma |
40 |
AndoSan™ (Agaricus blazei-based) |
60 ml/day |
2016 |
Agaricus blazei (Royal Sun Agaric) |
Effect of a Medicinal Agaricus blazei Murill-Based Mushroom Extract AndoSan™ on Symptoms, Fatigue, and Quality of Life in Patients with Ulcerative Colitis |
50 |
AndoSan™ (Agaricus blazei-based) |
60 ml/day |
2016 |
Agaricus blazei (Royal Sun Agaric) |
Effect of the Medicinal Agaricus blazei Murill-Based Mushroom Extract AndoSan™ on Symptoms, Fatigue, and Quality of Life in Patients with Crohn’s Disease |
50 |
AndoSan™ (Agaricus blazei-based) |
60 ml/day |
2017 |
Agaricus blazei (Royal Sun Agaric) |
Royal Sun Culinary-Medicinal Mushroom Agaricus brasiliensis Supplement in Training Capacity Improvement |
5 |
Fruiting Body |
Not specified |
2016 |
Agaricus blazei (Royal Sun Agaric) |
Cytokine Levels After Consumption of a Medicinal Agaricus blazei Murill-Based Mushroom Extract AndoSan™ in Patients with Crohn’s Disease and Ulcerative Colitis |
50 |
AndoSan™ (Agaricus blazei-based) |
60 ml/day |
2006 |
Agaricus blazei (Royal Sun Agaric) |
Effects on Gene Expression and Viral Load of a Medicinal Extract from Agaricus blazei in Patients with Chronic Hepatitis C Infection |
5 |
Fruiting Body Extract |
60 ml/day |
2004 |
Agaricus blazei (Royal Sun Agaric) |
Natural Killer Cell Activity and Quality of Life Improved by Agaricus blazei Murill Kyowa in Gynecological Cancer Patients Undergoing Chemotherapy |
100 |
Fruiting Body Extract |
Not specified |
2016 |
Antrodia (Taiwanofungus) |
Efficacy and safety of oral Antrodia cinnamomea mycelium in mildly hypertensive adults: A randomized controlled pilot clinical study |
41 |
Pure Mycelium |
1260 mg/day |
2022 |
Antrodia (Taiwanofungus) |
A Botanical Drug Extracted From Antrodia cinnamomea – A First-in-human Phase I Study in Healthy Volunteers |
18 |
LEAC-102 – Purified Compound |
500-3000 mg/day |
2016 |
Antrodia (Taiwanofungus) |
A preliminary randomised controlled study of short-term Antrodia cinnamomea treatment combined with chemotherapy for patients with advanced cancer |
37 |
Pure Mycelium |
80 ml/day |
2017 |
Antrodia (Taiwanofungus) |
Complementary Efficacy of Antrodia cinnamomea Mycelia on Patients with Chronic Hepatitis C Virus Infection: A Randomized Controlled Pilot Clinical Study |
60 |
Pure Mycelium |
4680 mg/day |
2020 |
Antrodia (Taiwanofungus) |
A Pilot Study to Assess Food Safety and Potential Cholesterol-Lowering Efficacy of Antrodia cinnamomea Solid-State Cultivated Mycelium in Healthy Adults |
32 |
Solid-State Mycelium |
Not specified |
2020 |
Antrodia (Taiwanofungus) |
Hepatoprotective Effect of Antrodia cinnamomea Mycelium in Patients with Nonalcoholic Steatohepatitis: A Randomized, Double-Blind, Placebo-Controlled Trial |
28 |
Pure Mycelium |
1260 mg/day |
2023 |
Antrodia (Taiwanofungus) |
Hepatoprotective effect of Antrodia Cinnamomea mycelia extract in subhealth Japanese adults- a randomized, double-blind, placebo-controlled clinical study |
Not specified |
Mycelium Extract |
Not specified |
2019 |
Antrodia (Taiwanofungus) |
Phase II multicenter study of antroquinonol in patients with stage IV non-small cell lung cancer who have failed at least two lines of anti-cancer therapy |
Not specified |
Antroquinonol – Purified Compound |
Not specified |
2017 |
Antrodia (Taiwanofungus) |
Effects of Antrodia Camphorata Mycelia Extract Containing Antroquinonol on Lowering Low-Density Lipoprotein Cholesterol: A Randomized Double-Blind Study |
26 |
Extract containing Antroquinonol |
25 mg w/ 0.68 mg of Antroquinono |
2015 |
Antrodia (Taiwanofungus) |
A Phase I Multicenter Study of Antroquinonol in Patients with Metastatic Non-Small-Cell Lung Cancer Who Have Received at Least Two Prior Systemic Treatment Regimens, Including One Platinum-Based Chemotherapy Regimen |
13 |
Antroquinonol – Purified Compound |
50-600 mg |
2024 |
Reishi (Ganoderma lucidum) |
Ganoderma lucidum Dry Extract Supplementation Modulates T Lymphocyte Function in Older WomenGanoderma lucidum Dry Extract Supplementation Modulates T Lymphocyte Function in Older Women |
60 |
Fruiting Body Extract |
|
2022 |
|
A Randomized Controlled Trial on Pleurotus eryngii Mushrooms with Antioxidant Compounds and Vitamin D2 in Managing Metabolic Disorders |
100 |
Whole mushroom In Snack |
6000 mg/day |
2014 |
Oyster Mushrooms (Pleurotus sp.) |
Anti-allergic Effect of Pleuran (β-glucan from Pleurotus ostreatus) in Children with Recurrent Respiratory Tract Infections |
175 |
Pleuran (β-glucan from P. ostreatus) |
10 mg/kg/day (in syrup with vitamin C), 6 months |
2011 |
Oyster Mushrooms (Pleurotus sp.) |
Antihyperlipidemic effects of Pleurotus ostreatus (oyster mushrooms) in HIV-infected individuals taking antiretroviral therapy |
25 |
Freeze-dried P. ostreatus powder |
15,000 mg/day (15 g/day) |
2025 |
Oyster Mushrooms (Pleurotus sp.) |
Beneficial effects of pleuran on asthma control and respiratory tract-infection frequency in children with perennial asthma |
230 |
Pleuran (β-glucan from P. ostreatus) |
200 mg/day (100 mg pleuran + 100 mg vitamin C), 24 weeks |
2015 |
Oyster Mushrooms (Pleurotus sp.) |
Beta-(1,3/1,6)-D-glucan Helps to Decrease Opportunistic Infections in Crohn’s Disease Patients Treated with Biological Therapy |
53 |
Pleuran (β-glucan from P. ostreatus) |
100 mg/day (pleuran only), 12 months |
2022 |
Oyster Mushrooms (Pleurotus sp.) |
Beta-(1,3/1,6)-D-glucan from Pleurotus ostreatus in the prevention of recurrent respiratory tract infections: An international, multicentre, open-label, prospective study |
1030 |
Pleuran (β-glucan from P. ostreatus) |
10 mg/day (β-glucan) + 10 mg vitamin C, 3 months |
2024 |
Oyster Mushrooms (Pleurotus sp.) |
Consuming Mushrooms When Adopting a Healthy Mediterranean-Style Dietary Pattern Does Not Influence Short-Term Changes of Most Cardiometabolic Disease Risk Factors in Healthy Middle-Aged and Older Adults |
60 |
Whole mushrooms |
84000 mg/day |
2022 |
Oyster Mushrooms (Pleurotus sp.) |
Dietary Supplementation with Oyster Culinary-Medicinal Mushroom, Pleurotus ostreatus (Agaricomycetes), Reduces Visceral Fat and Hyperlipidemia in Inhabitants of a Rural Community in Mexico |
30 |
Whole mushrooms |
1 kg/week |
2010 |
Oyster Mushrooms (Pleurotus sp.) |
Effect of Pleuran (β-glucan from Pleurotus ostreatus) supplementation on cellular immune response after intensive exercise in elite athletes |
20 |
Pleuran (β-glucan from P. ostreatus) |
100 mg/day β-glucan + 100 mg vitamin C, 2 months |
2024 |
Oyster Mushrooms (Pleurotus sp.) |
Effect of Pleurotus ostreatus Water Extract Consumption on Blood Parameters and Cytokine Values in Healthy Volunteers |
x |
Water extract of P. ostreatus |
100 mL/day (38.1 mg β-glucan/100 mL), 29 days |
2024 |
Oyster Mushrooms (Pleurotus sp.) |
Effects of an ergothioneine-rich Pleurotus sp. on skin moisturizing functions and facial conditions: a randomized, double-blind, placebo-controlled trial |
80 |
Pleurotus tablets rich in ergothioneine |
25 mg/day ergothioneine (from 5.8 g dried mushroom), 12 weeks |
2013 |
Oyster Mushrooms (Pleurotus sp.) |
Effects of Pleurotus ostreatus on Blood Pressure and Glycemic Status of Hypertensive Diabetic Male Volunteers |
27 |
Pleurotus powder in capsules |
3000 mg/day |
2020 |
Oyster Mushrooms (Pleurotus sp.) |
Efficacy of Pleuran (β-Glucan from Pleurotus ostreatus) in the Management of Herpes Simplex Virus Type 1 Infection |
90 |
Pleuran (β-glucan from P. ostreatus) |
Acute phase: 300 mg/day; Preventive phase: 100 mg/day, both with vitamin C & zinc |
2016 |
Oyster Mushrooms (Pleurotus sp.) |
Enhancement of the Th1-phenotype immune system by the intake of Oyster mushroom (Tamogitake) extract in a double-blind, placebo-controlled study |
41 |
Water extract of Pleurotus cornucopiae (Tamogitake) |
80 mL/day (24 mg β-glucan), 8 weeks |
2014 |
Oyster Mushrooms (Pleurotus sp.) |
Hypoglycaemic Activity of Culinary Pleurotus ostreatus and P. cystidiosus Mushrooms in Healthy Volunteers and Type 2 Diabetic Patients on Diet Control and the Possible Mechanisms of Action |
44 (22 per group healthy volunteers), 28 (14 per group diabetics) |
Freeze-dried mushroom powder (P. ostreatus or P. cystidiosus) |
50 mg/kg body weight |
2021 |
Oyster Mushrooms (Pleurotus sp.) |
Immunomodulation with β-glucan from Pleurotus ostreatus in patients with endocrine-dependent breast cancer |
195 (49 in treatment group) |
Pleuran (β-glucan from P. ostreatus) |
700 mg/day or 100–700 mg/day cyclical over 15 months |
2013 |
Oyster Mushrooms (Pleurotus sp.) |
Immunomodulatory effect of pleuran (β-glucan from Pleurotus ostreatus) in children with recurrent respiratory tract infections |
175 |
Pleuran + Vitamin C |
10 mg pleuran and 10 mg vitamin C per mL; 1 mL per 5 kg body weight |
2011 |
Oyster Mushrooms (Pleurotus sp.) |
Pleuran (β-glucan from Pleurotus ostreatus) supplementation, cellular immune response and respiratory tract infections in athletes |
50 |
Pleuran + Vitamin C |
200 mg/day (100 mg β-glucan + 100 mg vitamin C), 3 months |
2022 |
Oyster Mushrooms (Pleurotus sp.) |
Pleurotus eryngii improves postprandial glycaemia, hunger and fullness perception, and enhances ghrelin suppression in people with metabolically unhealthy obesity |
19 |
Cooked Whole Mushroom |
Not specified |
2017 |
Oyster Mushrooms (Pleurotus sp.) |
Preventive effect of pleuran (β-glucan from Pleurotus ostreatus) in children with recurrent respiratory tract infections – open-label prospective study |
191 |
Pleuran + Vitamin C |
10 mg pleuran + 10 mg vitamin C per mL, dosed at 1 mL per 5 kg body weight) |
2023 |
Oyster Mushrooms (Pleurotus sp.) |
The Short-Term Variation of Human Gut Mycobiome in Response to Dietary Intervention of Different Macronutrient Distributions |
28 |
Whole Mushroom Cooked |
Not specified (dietary exposure only) |
2015 |
Oyster Mushrooms (Pleurotus sp.) |
β-Glucan-based cream (containing pleuran isolated from Pleurotus ostreatus) in supportive treatment of mild-to-moderate atopic dermatitis |
105 |
Topical Pleuran Cream |
Topical: 0.25% cream, 2–3x/day |
2011 |
Oyster Mushrooms (Pleurotus sp.) |
Lipid Lowering Effects of Oyster Mushroom (Pleurotus ostreatus) in HumansLipid Lowering Effects of Oyster Mushroom (Pleurotus ostreatus) in Humans |
20 |
Freeze-dried Pleurotus ostreatus in soup |
30 g/day freeze-dried (equiv. 300 g fresh) |
2017 |
Reishi (Ganoderma lucidum) |
The Role of Ganoderma Lucidum Uptake on Some Hematological and Immunological Response in Patients with Coronavirus (COVID-19) |
71 |
Ganoderma Beta-Glucan |
750 mg/day |
2003 |
Ophiocordyceps sinensis |
CordyMax reduces serum oxidized LDL-cholesterol and increases HDL-cholesterol in humans with reduced HDL-cholesterolCordyMax reduces serum oxidized LDL-cholesterol and increases HDL-cholesterol in humans with reduced HDL-cholesterol |
85 |
CS-4 |
3000 mg/day |
1985 |
Lion’s Mane (Hericium erinaceus) |
A Double-Blind Study on Effectiveness of Hericium erinaceus Pers Therapy on Chronic Atrophic Gastritis: A Preliminary ReportA Double-Blind Study on Effectiveness of Hericium erinaceus Pers Therapy on Chronic Atrophic Gastritis: A Preliminary Report |
50 |
Hericium erinaceus extract |
Not specified (3-month treatment) |
2023 |
Lion’s Mane (Hericium erinaceus) |
Acute Effects of Naturally Occurring Guayusa Tea and Nordic Lion’s Mane Extracts on Cognitive Performance |
40 |
Lion’s Mane fruiting body extract (Nordic) |
1000 mg single dose |
2025 |
Hericium erinaceus |
Acute effects of a standardised extract of Hericium erinaceus (Lion’s Mane mushroom) on cognition and mood in healthy younger adults: a double-blind randomised placebo-controlled study |
18 |
10:1″ Fruiting Body Extract |
3000 mg |